Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks: A Survey on Self-perceived Food Sensitivity in FMF Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Familial Mediterranean Fever (FMF) is a chronic hereditary autoinflammatory disease caused by mutations in the MEditerranean FeVer (MEFV) gene which codes for pyrin. Dysfunction of this protein determines an inappropriate response to inflammatory stimuli. The clinical course of the disease is characterized by recurrent episodes of fever and inflammation of the serous membranes, which manifest with chest, abdominal and joint pain. Several studies suggest a possible association between acute FMF attacks and dietary triggers, including wheat. However, it is still unclear to what extent wheat is responsible for the reactivation of FMF and if, between one acute attack and another, patients with FMF experience other symptoms, both gastrointestinal and extraintestinal, characteristic of gluten/wheat sensitivity not linked to celiac disease or immunoglobulin E (IgE)-mediated wheat allergy (i.e. Non-Celiac Wheat Gluten/Sensitivity, NCGS/NCWS). Therefore, this study aims to evaluate the appearance of symptoms compatible with an acute attack of FMF following the ingestion of wheat or other foods, and the prevalence of self-perceived gluten/wheat sensitivity in patients with FMF.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients, of both sexes, aged between 6 months and 80 years, affected by FMF, classified according to the Eurofever/PRINTO criteria.

• Patients able to understand and complete the questionnaires independently (or, in the case of pediatric ones, analyzed through the answers provided by parents).

Locations
Other Locations
Italy
University Hospital of Palermo
RECRUITING
Palermo
Contact Information
Primary
Pasquale Mansueto, MD
pasquale.mansueto@unipa.it
3477279879
Backup
Aurelio Seidita, MD
aurelio.seidita@unipa.it
3209150370
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 60
Treatments
FMF patients
Patients, of both sexes, aged between 6 months and 80 years, affected by FMF, classified according to the Eurofever/PRINTO criteria
Control subjects
Subjects of the vaccination center of the University Hospital 'Paolo Giaccone' of Palermo, Italy
Sponsors
Leads: University of Palermo

This content was sourced from clinicaltrials.gov